dr agarwal’s health Care Share Price Target : Are you thinking of investing in dr agarwal’s health care shares? Want to know its future price target? In this guide, we will discuss dr agarwal’s health care share price target for the year 2025, 2026, 2030. Along with this, we will do a complete fundamental analysis to help you make the right decision.
OUR BUSINESS
Our Company incorporation dated April 19, 2010 We provide a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact lenses and accessories, and eye care related pharmaceutical products.
we had a market share of approximately 25% of the total eye care service chain market in India during the Financial Year 2024.
Our offerings cover :-
• Services, which comprise the following.
▪ Surgeries.
Cataract surgeries :- We offer cataract surgical treatments at our Facilities, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery and glued intraocular lens treatments.
Refractive surgeries :- Our refractive surgeries include surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens.
Primary refractive treatments include laser-assisted in-situ keratomileusis (“LASIK”) surgeries, small incision lenticule extraction (“SMILE”)
treatments, implantable collamer lens treatment and photo-refractive keratectomy.
Other surgeries :- We also offer a range of other surgical treatments for eye ailments, such as surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty and surgeries for the treatment of glaucoma and pterygium.
Consultations, diagnoses and non-surgical treatments: We also offer doctor consultation services, diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment.
Dr. Amar Agarwal, who has more than 35 years of clinical experience in the eye care services industry and has received several awards recognizing his contribution to ophthalmology.
OUR COMPETITIVE STRENGTHS
Largest eye care services provider in India with a trusted brand :-
we are India’s largest eye care service chain by revenue from operations for the Financial Year 2024, with approximately 1.7 times the revenue from operations of the second-largest eye care service chain in the country during such period.
we have 193 Facilities in India spanning 14 states and 4 union territories, and 16 Facilities spread across nine countries in Africa.
we have a diversified presence across Tier-I cities (where 70 of our Facilities are located) and other cities (where 123 of our Facilities are located) in India.
End-to-end, comprehensive eye care services offering :-
We are an end-to-end eye care services provider offering a comprehensive set of services, which allows us to cater to all ophthalmic needs of our patients.
We provide a comprehensive range of eye care services and products, covering cataract surgeries, refractive treatments and other surgeries; and other services, such as consultations, clinical investigations and nonsurgical treatments; along with optical and eye care related pharmaceutical products.
In addition, standard operating procedures (“SOPs”) are vital growth drivers for eye care service chains in India.
SOPs ensure consistent, high-quality patient care across all centers, building trust and reputation.
We endeavour to offer a standardized level of experience to our patients across all our Facilities by streamlining our systems and operating protocols.
Our Facilities :-
follow similar operating and medical protocols across locations to smoothen the experience of our patients throughout their journey with us, including navigating through registration, optometrist check-ups, doctor consultations, counselling, diagnosis, and non-surgical treatments, surgeries, and post-surgery care, as well as sales of optical and eye care-related pharmaceutical products.
A typical patient experience at our Facilities is depicted below :-
Proven clinical excellence driven by a strong clinical board and history of surgical innovations :-
• Quality control committee, which oversees the regular audit of clinical aspects.
This committee oversees the audit of clinical aspects of our Facilities on multiple parameters, such as the formulation of protocols and policies, ensuring transparency in reporting adverse events, analyzing adverse events, identifying and addressing areas of improvement and collaborating with other departments and stakeholders to develop and implement quality improvement initiatives.
• Education committee, for continuous and ongoing training of doctors.
This committee is responsible for ensuring continuous training of doctors, optometrists, and para-medical staff, and to conduct conferences and conventions in this regard.
• Drug and medical devices committee, to control the introduction and usage of new pharmaceutical products and intraocular lens (“IOLs”), and to streamline the process of approval / upgradation/ replacement of medical devices.
• Research and development committee, which conducts clinical trials in cataract, glaucoma, corneal and retinal specialties. During the six months ended September 30, 2024 and the Financial Years 2024, 2023 and 2022, this committee has completed 28 clinical research studies, with 17 studies ongoing.
Our clinical board has also established an international advisory board comprising doctors from the United States of America to advise on improvements in clinical practices in ophthalmology, and a specialty advisory board comprising 31 experts to focus on nine specialised services.
We provide a comprehensive range of eye care services, covering cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell optical and eye care related pharmaceutical products through a network of Facilities across 14 states and four union territories with 117 cities in India, and nine countries in Africa.
Comparison with listed industry peers
Dr. Agarwal’s Health Care Limited
Listed Peers
- Apollo Hospitals Enterprise Limited
- Max Healthcare Institute Limited
- Fortis Healthcare Limited
- Global Health Limited
- Narayana Hrudayalaya Limited
- Krishna Institute of Medical Sciences Limited
- Aster DM Healthcare Limited
- Rainbow Children’s Medicare Limited
Dr Agarwal’s Health Care Fundamentals
| Fundamentals | Dr Agarwal's Health Care |
| Market Cap | ₹Cr |
| 52 Week High | |
| 52 Week Low | |
| NSE Symbol | |
| ROE | |
| P/E Ratio | |
| EPS | |
| P/B Ratio | |
| Dividend Yield | |
| Industry P/E | |
| Book Value | |
| Debt to Equity | |
| Stock Face Value |
Dr Agarwal’s Health Care Shareholding Pattern
| Promoters | % |
| Retail & Others | % |
| DII | % |
| FII | % |
| Mutual Funds | % |
Dr Agarwal’s Health Care Financial Reports
| Sector | Year (2024) |
| Revenue | |
| Expense | |
| Profit Before Tax | |
| Net Profit |
Dr Agarwal’s Health Care Share Price Target 2025
The share price of Dr Agarwal’s Health Care may Ups & Down. According to our analysis levels, the minimum price of Dr Agarwal’s Health Care share in 2025 can be ₹ and the maximum price can be ₹.
| Month Wise (Year 2025) | Target Price |
| January | ₹ |
| February | ₹ |
| March | ₹ |
| April | ₹ |
| May | ₹ |
| June | ₹ |
| July | ₹ |
| August | ₹ |
| September | ₹ |
| October | ₹ |
| November | ₹ |
| December | ₹ |
Dr Agarwal’s Health Care Share Price Target 2026
The share price of Dr Agarwal’s Health Care may Ups & Down. According to our analysis levels, the minimum price of Dr Agarwal’s Health Care share in 2026 can be ₹ and the maximum price can be ₹.
| Month Wise (Year 2026) | Target Price |
| January | ₹ |
| December | ₹ |
Dr Agarwal’s Health Care Share Price Target 2030
The share price of Dr Agarwal’s Health Care may Ups & Down. According to our analysis levels, the minimum price of Dr Agarwal’s Health Care share in 2030 can be ₹ and the maximum price can be ₹.
| Month Wise (Year 2030) | Target Price |
| January | ₹ |
| December | ₹ |
Dr Agarwal’s Health Care Share Price Target 2040
The share price of Dr Agarwal’s Health Care may Ups & Down. According to our analysis levels, the minimum price of Dr Agarwal’s Health Care share in 2040 can be ₹ and the maximum price can be ₹.
| Month Wise (Year 2040) | Target Price |
| January | ₹ |
| December | ₹ |
Dr Agarwal’s Health Care Share Price Target 2050
The share price of Dr Agarwal’s Health Care may Ups & Down. According to our analysis levels, the minimum price of Dr Agarwal’s Health Care share in 2050 can be ₹ and the maximum price can be ₹.
| Month Wise (Year 2050) | Target Price |
| January | ₹ |
| December | ₹ |
